Internal Medicine Doctors in Swansea, IL Accepting Medicare

8 Internal Medicine doctors found. Showing 1 - 8

Deborah K Mcdermott, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4 Park Pl, Swansea, IL 62226 Phone: 618-277-7500    Fax: 618-277-4236

Dr. Samuel A. Burstein, M.D. Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4000 N Illinois Ln, Suite C, Swansea, IL 62226 Phone: 618-233-8000    Fax: 618-233-8070

Khaja G Mohsin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Emerald Ter, Swansea, IL 62226 Phone: 618-235-6780    Fax: 618-235-6740

Dr. Thomas F Tse, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 1 Holly Ridge Ct, Swansea, IL 62226 Phone: 618-520-3003    Fax: 618-277-3926

Dr. Morton A Levy, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 4000 North Illinois, Swansea, IL 62226 Phone: 618-236-1000    Fax: 618-236-1299

John Thomas English, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Park Pl, Swansea, IL 62226 Phone: 618-277-7500    Fax: 618-277-4236

Victoria L Jansen, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4 Park Pl, Swansea, IL 62226 Phone: 618-277-7500    Fax: 618-277-4236

Dr. Charles W Ampadu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 15 Park Pl, Swansea, IL 62226 Phone: 618-257-0780    Fax: 618-257-0715

News Archive

Study examines bullying, recent alcohol use and heavy drinking episodes among school students

A new study out of the University of Cincinnati finds that both school bullies and their victims are likely to abuse alcohol after a bullying episode. Keith King, a University of Cincinnati professor of health promotion, along with Rebecca Vidourek, a UC assistant professor of health promotion, will present early findings of a new study on Oct. 29, at the 140th Annual Meeting of the American Public Health Association in San Francisco.

Effective postoperative pain control using continuous peripheral nerve block reduces days of hospitalization

Effective postoperative pain control using continuous peripheral nerve block reduced average length-of-stay by nearly a day, University of Pittsburgh School of Medicine physicians reported today during the 81st Clinical and Scientific Congress of the International Anesthesia Research Society at the Buena Vista Palace in Orlando, Fla.

ARI-4175 drug may treat colorectal cancer patients with KRAS mutation

When combined with other treatments, the drug cetuximab-which works by slowing or stopping the growth of cancer cells-has been shown to extend survival in certain types of cancer, including metastatic colorectal cancers. Unfortunately, about 40 percent of colorectal cancer patients-specifically those who carry a mutated form of a gene called KRAS-do not respond to the drug. Researchers at Fox Chase Cancer Center in Philadelphia, however, have been working on a way to overcome this resistance to cetuximab by unleashing a second cetuximab driven mechanism using a novel drug called ARI-4175.

Endologix second-quarter total revenue increases 19% to $15.7 million

Endologix, Inc., developer of minimally invasive treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2010.

2010 GAPS sheds light on the painful reality of what life is like for gout patients

The 2010 Gout Attitudes Patient Survey, a new study of Americans with gout, released by Men's Health Network, sheds light on the painful reality of what life is like for the approximately five million Americans who live with this condition. Of those surveyed, 69 percent described the pain of a gout attack as "miserable," yet a quarter of gout patients feel that those without gout perceive them as overreacting to attacks, and 67 percent feel as though others do not take the condition seriously.

Read more Medical News

› Verified 6 days ago